MAS in SLE is thought to arise from both genetic predispositions (e.g., IRF5 or NLRC4 mutations) and immune triggers, which together amplify innate immune responses and cytokine release (including IL-1, IL-6, IL-18) [8,9]. This evidence concerns the gene IRF5 and systemic lupus erythematosus.